These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1530963)

  • 41. [Virion protein synthesis in the lungs in experimental influenzal infection in animals].
    Prokudina EN; Semenova NP; Zhdanov VM
    Vopr Virusol; 1984; 29(1):14-9. PubMed ID: 6710975
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Role of Glutathione Reductase in Influenza Infection.
    Hong KS; Pagan K; Whalen W; Harris R; Yang J; Stout-Delgado H; Cho SJ
    Am J Respir Cell Mol Biol; 2022 Oct; 67(4):438-445. PubMed ID: 35767671
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influenza type A virus-mediated adherence of type 1a group B streptococci to mouse tracheal tissue in vivo.
    Jones WT; Menna JH
    Infect Immun; 1982 Nov; 38(2):791-4. PubMed ID: 6754623
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Role of lipid peroxidation in the pathogenesis of influenza and search for antiviral protective agents].
    Chetverikova LK; Inozemtseva LI
    Vestn Ross Akad Med Nauk; 1996; (3):37-40. PubMed ID: 8672960
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influenza virus infection and bacterial clearance in young adult and aged mice.
    Wyde PR; Six HR; Ambrose MW; Throop BJ
    J Gerontol; 1989 Sep; 44(5):B118-24. PubMed ID: 2475539
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of anti-interferon serum of influenza virus infection in mice.
    Hoshino A; Takenaka H; Mizukoshi O; Imanishi J; Kishida T; Tovey MG
    Antiviral Res; 1983 Mar; 3(1):59-65. PubMed ID: 6191656
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Quercetin on lipid peroxidation and changes in lung morphology in experimental influenza virus infection.
    Kumar P; Sharma S; Khanna M; Raj HG
    Int J Exp Pathol; 2003 Jun; 84(3):127-33. PubMed ID: 12974942
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pulmonary oxygen toxicity in mice is characterized by alterations in ascorbate redox status.
    Rusakow LS; Han J; Hayward MA; Griffith OW
    J Appl Physiol (1985); 1995 Nov; 79(5):1769-76. PubMed ID: 8594040
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibition of influenza infection by glutathione.
    Cai J; Chen Y; Seth S; Furukawa S; Compans RW; Jones DP
    Free Radic Biol Med; 2003 Apr; 34(7):928-36. PubMed ID: 12654482
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular mechanism of complex infection by bacteria and virus analyzed by a model using serratial protease and influenza virus in mice.
    Akaike T; Molla A; Ando M; Araki S; Maeda H
    J Virol; 1989 May; 63(5):2252-9. PubMed ID: 2522998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A comparative study of free radicals in vertebrates--II. Non-enzymatic antioxidants and oxidative stress.
    López-Torres M; Pérez-Campo R; Cadenas S; Rojas C; Barja G
    Comp Biochem Physiol B; 1993; 105(3-4):757-63. PubMed ID: 8365120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The effect of gangliosides on experimental influenza infection].
    Bukrinskaia AG; Petrova IG; Podcherniaeva RIa; Slepushkin VA; Bergel'son LD
    Vopr Virusol; 1989; 34(4):405-8. PubMed ID: 2588548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Proteolytic enzymes and their inhibitors in experimental influenzal infection].
    Degtiarenko VI; Lozitskiĭ VP; Ganchenko MG
    Vopr Virusol; 1977; (1):36-40. PubMed ID: 910440
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Protease inhibitor suppression of influenza virus replication in the lungs of infected mice].
    Zhirnov OP; Ovcharenko AV; Bukrinskaia AG
    Vopr Virusol; 1983; (3):371-3. PubMed ID: 6193646
    [No Abstract]   [Full Text] [Related]  

  • 55. Oxidants and antioxidants in viral diseases: disease mechanisms and metabolic regulation.
    Peterhans E
    J Nutr; 1997 May; 127(5 Suppl):962S-965S. PubMed ID: 9164274
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Respiratory diseases in cyclophosphamide-treated mice. II. Decreased virulence of PR8 influenza virus.
    Singer SH; Noguchi P; Kirschstein RL
    Infect Immun; 1972 Jun; 5(6):957-60. PubMed ID: 4635505
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of tuberculin hypersensitivity during influenza infection in mice.
    Massanari RM
    Infect Immun; 1979 May; 24(2):501-7. PubMed ID: 457284
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The ratio of oxidized and reduced forms of selected antioxidants as a possible marker of oxidative stress in humans.
    Kanďár R
    Biomed Chromatogr; 2016 Jan; 30(1):13-28. PubMed ID: 26053056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of influenza virus strains on lipid metabolism of infected HEK cells.
    Jerkofsky MA; Dority MD
    Intervirology; 1990; 31(2-4):139-46. PubMed ID: 2165041
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Modification of mouse resistance to A/Aichi/2/68 influenza virus by a glucocorticoid immunosuppressant kenalog].
    Shishkina LN; Sergeev AN; P'iankova OG; Bulychev LG; Petrishchenko VA; Shishkin AV; Buriak GA; Bocharov EF; Zhukov VA
    Vopr Virusol; 1999; 44(6):272-5. PubMed ID: 10665064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.